English | Español
Robert Hadley | Jun 29, 2017

Amgen hoping to extend use of Xgeva to prevent fractures in myeloma patients
Robert Hadley | Jun 28, 2017

Pfizer a step closer to making $17B gamble on biosimilars pay off
John Breslin | Jun 26, 2017

Amid Senate health bill debate, skeptics warn about CBO figures

Ruth de Jauregui | Jun 25, 2017

Researchers focus on relationship between microbes, cancer
Robert Hadley | Jun 25, 2017

Potential leukemia drug better aimed at muscular dystrophy, NIH says
Robert Hadley | Jun 22, 2017

Phase 3 trial of Pfizer’s prostate cancer drug could yield results two years early
Michael McGrady | Jun 22, 2017

FDA chief wants to speed up approvals for digital health tech
Ruth de Jauregui | Jun 21, 2017

Health care marketplace forecast brings call for more than just a fix

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’